ArticleHeliyon2024

Immunogenicity and durability against Omicron BA.1, BA.2 and BA.4/5 variants at 3-4 months after a heterologous COVID-19 booster vaccine in healthy adults with a two-doses CoronaVac vaccination.

Suvichada Assawakosri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.